Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureus

Shaohui Yin, Robert S. Daum, Susan Boyle-Vavra
Shaohui Yin
1Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert S. Daum
1Department of Pediatrics
2Committee on Microbiology
3Committee on Molecular Medicine, The University of Chicago, Chicago, Illinois 60637
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Boyle-Vavra
1Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sboyleva@midway.uchicago.edu
DOI: 10.1128/AAC.50.1.336-343.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Northern blotting analysis of vraS transcripts in wild-type strain RN4220 and the vraS mutant strain (M1) treated with VAN or OXA. (A) Map of the four ORFs contained in the vraSR operon illustrating the probe (line beneath map) used in Northern blotting analysis and the binding sites for primers (short arrows) (PE1 to PE4) used in the primer extension assay. The vraSR probe was PCR amplified using the primers vraSRprobeF and vraSRprobeR. The vraSR mutant (M1) contains an ermC cassette inserted into the EcoRI site of the chromosomal vraS gene, as depicted above the map. (B) Northern blot of RNA isolated from uninduced cultures (U) or cultures induced by VAN (2 μg/ml) or OXA (1 μg/ml). Membranes were hybridized with a vraSR-specific probe (shown beneath the map in panel A). Overnight cultures of S. aureus strains were diluted 1:100 in tryptic soy broth (10 ml in a 50-ml conical Falcon tube), shaken at 250 rpm, and grown at 37°C. After a 1-h incubation, the cultures were treated and incubated for another hour. The vraSR probe was PCR labeled with [α-32P]dATP (Amersham) using the Prime-a-Gene labeling system (Promega). The hybridized blots were washed with 0.1× SSC buffer (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl sulfate four times at 70°C, each time for 30 min. (C) Results from primer extension (PE) analysis of MRSA strain IL-A with the use of primers PE1, PE2, and PE3. The asterisk indicates the major tsp. The reaction product was mixed with half the volume of a sequencing stop solution, denatured, and applied to a 5% sequencing gel. The sequencing ladder (lanes labeled G, A, T, C) was prepared by using an fmol DNA cycle sequencing system (Promega) with the same primer used in the primer extension reaction.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Analysis of vraSR-lacZ fusions by β-galactosidase assay in wild-type strain RN4220 and the vraSR mutant (M1). (A) Map of the DNA fragments (horizontal black bars beneath the map) PCR amplified from the vraSR operon from MRSA strain IL-A, which was used to produce the vraSR-lacZ fusions. PCR primers were designed with KpnI (forward primers) and BamHI (reverse primers) restriction enzyme recognition sequences to facilitate cloning of the fragments. Fragment coordinates are relative to the vraSR tsp determined as shown in Fig. 1C. Each square filled with diagonal lines at the end of each fragment represents the amino terminus of the corresponding ORF to which lacZ was joined. VP-462 and VP-262 terminate with the sixth codon of orf1, VP1 and VP1′ terminate with the sixth codon of vraS, and VP2′ and VP2 terminate with the sixth codon of vraR. To optimize translation of lacZ in S. aureus, each fragment was fused upstream of, and in frame with, the 33rd codon of a 3,051-bp lacZ fragment isolated by PCR from pCMVβ (primer pairs in Table 2). Each PCR fragment was digested with KpnI and BamHI and ligated upstream of the lacZ fragment (Table 2) in pAW8 (18). (B) β-Galactosidase assays of VAN-specific induction of vraSR-lacZ fusions in wild-type strain RN4220 and vraSR mutant strain M1. The data are the means of at least three experiments. Error bars represent the standard deviations of the means. (C) β-Galactosidase assays of OXA (Ox)-specific induction of vraSR-lacZ constructs harbored in RN4220 or strain M1. β-Galactosidase specific activity was expressed as nanomoles of product formed per minute per mg of protein at 37°C.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Analysis of pbp2-lacZ fusions by β-galactosidase assay in wild-type strain RN4220 and the vraSR mutant (M1). (A) Map of the pbp2 operon and PCR fragments (horizontal bars beneath map) encompassing its various regions that were fused upstream of and in frame with lacZ. The three tsp’s (P1, P1′, and P2) and various primers used in this study (half arrowheads) are shown relative to the prf and pbp2 ORFs. Coordinates are relative to the P1 tsp, with accession number AB035448 used as a reference sequence. The operon fragments in pPBP2-b, pPBP2-c, and pPBP2-d each terminate after the eighth codon of pbp2 (square filled with diagonal lines). The fragment in pPBP2-a terminates after the sixth codon of prfA (square filled with horizontal lines). (B) VAN-specific induction pbp2-lacZ fusions pPBP2-a (a), pPBP2-b (b), pPBP2-c (c), and pPBP2-d (d) in wild-type strain RN4220 and in M1. Con, RN4220 harboring vector containing only the lacZ insert. The data represent the means of at least three experiments. Error bars represent the standard deviations of the means. (C) OXA (Ox)-dependent induction of pbp2-lacZ fusions pPBP2-b (b) and pPBP2-c (c) in strains RN4220 and M1. β-Galactosidase specific activity was expressed as nanomoles of product formed per minute per mg of protein at 37°C.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Disk diffusion assay for induction of pbp2- and vraSR-lacZ fusions. Strain RN4220 (Wt) and the vraSR mutant strain (M1) carrying pbp2-lacZ fusions (pPBP2-b, pPBP2-c) or a vraSR-lacZ fusion (pVP-462) were diluted to the optical density of a 0.5 McFarland turbidity standard (BBL), swabbed onto tryptic soy agar containing TET (10 μg/ml) and X-Gal, overlaid with antibiotic-containing disks (Sensi-Disc; BBL), and incubated at 37°C overnight. Subsequent incubation at 4°C for 2 days intensified the blue color. The concentrations of the antibiotics were as follows: VAN, 30 μg; CTX, 30 μg; CEC, 30 μg; OXA (OX), 1 μg; FOX, 30 μg; BAC, 10 μg; ERY, 2 μg.

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Strains and plasmids

    Strain or plasmidRelevant featuresaReference or source
    S. aureus strains
        RN4220 S. aureus intermediate host strain (restriction negative) for cloning (derived from strain 8325-4) 6
        M1 vraSR mutant of RN4220 with ermC insertion in the EcoRI site of vraS, erythromycin resistantThis study
        IL-AMRSA clinical strain 2
    Plasmids
        pGEM-T Escherichia coli vector, ampicillin resistance (blaZ)Promega
        pAW8 S. aureus-E. coli shuttle vector, Tetr, intergenic region from pUC118, pAMα1 gram-positive ori and ColE1 ori from E. coliAkihito Wada
        pCMVβVector used as a source for lacZ geneClontech
        pALC80Used as a source for ermC gene; pSPT181 containing a 2.4-kb sar fragment carrying ermC gene, stable at 32°CAmbrose Cheung
        pCL52.1 E. coli-S. aureus shuttle plasmid; gram-positive Ts ori from pE194; Spxr; Tetr gene from pT181Chia Lee (10)
        pVRASR-1pGEM-T containing cloned vraSR PCR fragmentThis study
        pVRSASR-ermpVRASR-1 containing ermC in the EcoRI site of vraSThis study
        pVRASR-erm-pCL52.1PstI-digested pVRASR-erm ligated with PstI-digested pCL52.1This study
        pVP1pAW8 containing a translational fusion between the vraSR operon fragment, VP1, from strain IL-A and lacZ from pCMVβThis study
        pVP1′pAW8 containing a translational fusion between the vraSR operon fragment, VP1′, from strain IL-A and lacZ from pCMVβThis study
        pVP2pAW8 containing a lacZ translational fusion between the vraSR operon fragment, VP2, from MRSA strain IL-A and lacZ from pCMVβThis study
        pVP2′pAW8 containing translational fusion between vraSR operon fragment, VP2′, from MRSA strain IL-A and lacZ from pCMVβThis study
        pVP-262pAW8 containing a translational fusion between the VP-262 fragment from the vraSR operon from MRSA strain IL-A and lacZ from pCMVβThis study
        pVP-462pAW8 containing a translational fusion between the VP-462 fragment from the vraSR operon from MRSA strain IL-A and lacZ from pCMVβThis study
        pPBP2-bpAW8 containing a translational fusion between the pbp2 operon fragment, PBP2-b, from MRSA strain IL-A and lacZ from pCMVβThis study
        pPBP2-cpAW8 containing a translational fusion between the pbp2 operon fragment, PBP2-c, from MRSA strain IL-A and lacZ from pCMVβThis study
    • ↵ a The lacZ fragment in all lacZ fusions begins at the 33rd codon; ori, origin of replication; Ts, temperature sensitive.

  • TABLE 2.

    Primer pairs used for producing PCR fragments

    FragmentPrimerSize (bp)Resulting plasmid
    ForwardReverse
    lacZ fragment for creating fusionslacF2-BamHIlacR1-PstIpVRASRerm-pCL52.1
    vraSR operon fragmentsvraSR-FvraSR-R1,700pVRASRerm
        vraSR probevraSRprobeFvraSRprobeR2,022None (not cloned)
        VP1VraF1-KpnIVraR1-BamHI1,183pVP1
        VP1′VraF2-KpnIVraR1-BamHI1,513pVP1′
        VP2VraF3-KpnIVraR2-BamHI1,076pVP2
        VP2′VraF4-KpnIVraR2-BamHI2,218pVP2′
        VP-262VraF5-KpnIVraR3-BamHI412pVP-262
        VP-462VraF6-KpnIVraR3-BamHI612pVP-462
    pbp2 operon fragments
        PBP2-aPBP2F1-KpnIPBP2R1-PstI326pPBP2-a
        PBP2-bPBP2F1-KpnIPBP2R2-PstI955pPBP2-b
        PBP2-cPBP2F2-KpnIPBP2R2-PstI647pPBP2-c
        PBP2-dPBP2F3-KpnIPBP2R2-PstI431pPBP2-d

Additional Files

  • Figures
  • Tables
  • HTML Page - index.htslp

    Files in this Data Supplement:

    • Supplemental file 1 - Table of primer sequences
      MS Word document, 44.5K
PreviousNext
Back to top
Download PDF
Citation Tools
VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureus
Shaohui Yin, Robert S. Daum, Susan Boyle-Vavra
Antimicrobial Agents and Chemotherapy Dec 2005, 50 (1) 336-343; DOI: 10.1128/AAC.50.1.336-343.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureus
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureus
Shaohui Yin, Robert S. Daum, Susan Boyle-Vavra
Antimicrobial Agents and Chemotherapy Dec 2005, 50 (1) 336-343; DOI: 10.1128/AAC.50.1.336-343.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
cell wall
Gene Expression Regulation, Bacterial
Staphylococcus aureus

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596